CHARACTERISTICS OF A CELL-LINE ESTABLISHED FROM A T-CELL ACUTE-LEUKEMIA BY TRANSFECTION WITH THE BCL-2 GENE

被引:0
|
作者
ZHENG, CY
PABELLO, P
SKINNIDER, LF
机构
[1] UNIV SASKATCHEWAN,DEPT PATHOL,SASKATOON S7N 0W0,SK,CANADA
[2] UNIV SASKATCHEWAN,DEPT PEDIAT,SASKATOON S7N 0W0,SK,CANADA
[3] NORMAN BETHUNE UNIV MED SCI,DEPT ENVIRONM PATHOL,JILIN,PEOPLES R CHINA
关键词
ACUTE LEUKEMIA; BCL-2; LARGE GRANULAR LYMPHOCYTES; T CELL; TRANSFECTION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The bcl-2 gene product inhibits apoptosis and thus its over-expression may promote development of the malignant phenotype under certain circumstances. We have introduced the bcl-2 alpha and bcl-2 beta genetic elements into T cell acute lymphoblastic leukemic blasts. These transfectants were able to survive and grow in liquid culture with the establishment of cell lines while the untransfected blast cells died off. Thus transfection of the bcl-2 genes appears to give additional survival advantages to already malignant cells. Although the original leukemic blasts did not have cytoplasmic granules, the established transfectants have a morphology and surface marker profile compatible with large granular lymphoid cells.
引用
收藏
页码:181 / 186
页数:6
相关论文
共 50 条
  • [31] ACUTE-LEUKEMIA EXPRESSING THE GAMMA GENE-PRODUCT OF THE PUTATIVE 2ND T-CELL RECEPTOR
    GONZALEZSARMIENTO, R
    LEBIEN, TW
    BRADLEY, JG
    GREENBERG, JM
    SEIDMAN, JG
    ANG, S
    KERSEY, JH
    JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (04): : 1281 - 1284
  • [32] Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia
    Zhu, Lihua
    Zhang, Fan
    Shen, Qi
    Chen, Shaohua
    Wang, Xu
    Wang, Liang
    Yang, Lijian
    Wu, Xiuli
    Huang, Suming
    Schmidt, Christian A.
    Li, Yangqiu
    HEMATOLOGY, 2014, 19 (08) : 448 - 454
  • [33] TETRAPLOID CELL LINE IN A GIRL WITH ACUTE-LEUKEMIA
    FOADI, MD
    ACTA HAEMATOLOGICA, 1977, 57 (01) : 55 - 64
  • [34] ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
    Peirs, Sofie
    Matthijssens, Filip
    Goossens, Steven
    Van de Walle, Inge
    Ruggero, Katia
    de Bock, Charles E.
    Degryse, Sandrine
    Cante-Barrett, Kirsten
    Briot, Delphine
    Clappier, Emmanuelle
    Lammens, Tim
    De Moerloose, Barbara
    Benoit, Yves
    Poppe, Bruce
    Meijerink, Jules P.
    Cools, Jan
    Soulier, Jean
    Rabbitts, Terence H.
    Taghon, Tom
    Speleman, Frank
    Van Vlierberghe, Pieter
    BLOOD, 2014, 124 (25) : 3738 - 3747
  • [35] TARGETING BET FAMILY PROTEINS IMPROVES THE THERAPEUTIC EFFICACY OF BCL-2 INHIBITION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Peirs, S.
    Frismantas, V.
    Matthijssens, F.
    Lintermans, B.
    Pieters, T.
    Vandamme, N.
    Van Loocke, W.
    Berx, G.
    Poppe, B.
    Bourquin, J. P.
    Van Vlierberghe, P.
    HAEMATOLOGICA, 2016, 101 : 201 - 202
  • [36] IMMUNOGLOBULIN, T-CELL RECEPTOR AND BCL-2 GENE REARRANGEMENTS IN CUTANEOUS LYMPHOID LESIONS
    TJONG, J
    EYLONJONES, S
    URBANSKI, SJ
    KOSSAKOWSKA, AE
    LABORATORY INVESTIGATION, 1995, 72 (01) : A51 - A51
  • [37] Characteristics of T-cell immunity in patients with acute leukemia
    Parovichnikova, E. N.
    Galtseva, I. V.
    Vorobyev, I. A.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2006, 78 (07) : 18 - 25
  • [38] First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia
    Boidol, Bernd
    Kornauth, Christoph
    van der Kouwe, Emiel
    Prutsch, Nicole
    Kazianka, Lukas
    Gultekin, Sinan
    Hoermann, Gregor
    Mayerhoefer, Marius E.
    Hopfinger, Georg
    Hauswirth, Alexander
    Panny, Michael
    Aretin, Marie-Bernadette
    Hilgarth, Bernadette
    Sperr, Wolfgang R.
    Valent, Peter
    Simonitsch-Klupp, Ingrid
    Moriggl, Richard
    Merkel, Olaf
    Kenner, Lukas
    Jaeger, Ulrich
    Kubicek, Stefan
    Staber, Philipp B.
    BLOOD, 2017, 130 (23) : 2499 - 2503
  • [39] DOES THE ESTABLISHED CELL-LINE REPRESENT THE ORIGINAL LEUKEMIA CLONE
    NAEIM, F
    JENSEN, LA
    GATTI, RA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 211 - 211
  • [40] IMMUNOSUPPRESSIVE FACTOR PRODUCED BY A-B CELL-LINE DERIVED FROM AN ADULT T-CELL LEUKEMIA PATIENT
    MORI, N
    YAMASHITA, U
    TANAKA, Y
    NAGATA, K
    NAKATA, K
    ODA, S
    ETO, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1992, 56 (01) : 29 - 39